A1AX52

PR
Gene name
argH
Protein name
Argininosuccinate lyase
Names
ASAL, Arginosuccinase
Species
Ruthia magnifica subsp Calyptogena magnifica
KEGG Pathway
rma:Rmag_0784
EC number
4.3.2.1: Lyases acting on amides, amidines, etc
Protein Class

Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

1-49 (Predicted disordered autoinhibitory region) PR

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

References

Autoinhibited structure

Activated structure

1 structures for A1AX52

Entry ID Method Resolution Chain Position Source
AF-A1AX52-F1 Predicted AlphaFoldDB

No variants for A1AX52

Variant ID(s) Position Change Description Diseaes Association Provenance
No variants for A1AX52

No associated diseases with A1AX52

3 regional properties for A1AX52

Type Name Position InterPro Accession
conserved_site Fumarate lyase, conserved site 299 - 308 IPR020557
domain Fumarate lyase, N-terminal 30 - 324 IPR022761
domain Argininosuccinate lyase, C-terminal 387 - 454 IPR029419

Functions

Description
EC Number 4.3.2.1 Lyases acting on amides, amidines, etc
Subcellular Localization
  • Cytoplasm
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

1 GO annotations of cellular component

Name Definition
cytoplasm The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.

1 GO annotations of molecular function

Name Definition
argininosuccinate lyase activity Catalysis of the reaction: N-(L-arginino)succinate = fumarate + L-arginine.

1 GO annotations of biological process

Name Definition
arginine biosynthetic process via ornithine The chemical reactions and pathways resulting in the formation of arginine (2-amino-5-guanidinopentanoic acid) via the intermediate compound ornithine.

No homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
No homologous proteins
10 20 30 40 50 60
MTNDTQYKRH KTVLKEESRR TIQINKSWGG RFNEPTDEFV KIFGASIFFD KILAPYDIQG
70 80 90 100 110 120
SIAHATMLQE VGLLTENEKN KIIKGLERIL SEVKTGEFKW SITLEDIHMN IEARLVKMIG
130 140 150 160 170 180
DTGKKLHTGR SRNDQIVTDI RLYLRDQVDD ITNEIKRLQL VLADLAEKET NTIMPGFTHL
190 200 210 220 230 240
QAAQPISFGH HMMAYFEMLA RDVERLFDCR KRINSMPLGS AALAGTTYSI KRTRTAELLG
250 260 270 280 290 300
FERICLNSLD GVSDRDFVIE FLSTASIIMM HLSRFSEELI LWSSAQFNFI ELPDSFCTGS
310 320 330 340 350 360
SIMPQKKNPD VPELVRGKTG RVYGNLTSLL TIMKSQPLAY NKDNQEDKEP LFDTVDTLKA
370 380 390 400 410 420
CLRVFADMIP TIQIKRDNMY NSTKQGYTTA TDLADYLVNK GLPFRDAHKV VGKSVAYGIE
430 440 450 460 470
HQKDLSELSL EELQAFDSRI ENDVFEILSL EGSLNARNHL GATSPNQVKQ AIKIARKTLK